SCHEMBL2648293

SCHEMBL2648293

COC(=O)C(I)=CC1CCCCCCC1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.34
GRIK1 P39086 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
EPHX2 P34913 2/20 0.32
GRIK2 Q13002 1/20 0.31
EPHX1 P07099 6/20 0.31
GFER P55789 1/20 0.31
NPC1 O15118 2/20 0.30
RAB9A P51151 2/20 0.30
ADH1B P00325 1/20 0.30
ADH1C P00326 1/20 0.30
ADH1A P07327 1/20 0.30
ADH4 P08319 1/20 0.30
MAPT P10636 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2646341 1.00 NPSR1 (0.34) NPSR1GRIK1MEN1KMT2ASMN1; SMN2
SCHEMBL2645537 1.00 NPSR1 (0.34) NPSR1GRIK1MEN1KMT2ASMN1; SMN2
SCHEMBL2648288 1.00 NPSR1 (0.34) NPSR1GRIK1MEN1KMT2ASMN1; SMN2
SCHEMBL2648292 1.00 NPSR1 (0.34) NPSR1GRIK1MEN1KMT2ASMN1; SMN2
SCHEMBL2646345 1.00 NPSR1 (0.34) NPSR1GRIK1MEN1KMT2ASMN1; SMN2
SCHEMBL2646343 1.00 NPSR1 (0.34) NPSR1GRIK1MEN1KMT2ASMN1; SMN2
SCHEMBL2645539 1.00 NPSR1 (0.34) NPSR1GRIK1MEN1KMT2ASMN1; SMN2
SCHEMBL2645541 1.00 NPSR1 (0.34) NPSR1GRIK1MEN1KMT2ASMN1; SMN2
SCHEMBL2646427 0.98 GRIK1 (0.32) NPSR1GRIK1MEN1KMT2AGRIK2
SCHEMBL2646429 0.98 GRIK1 (0.32) NPSR1GRIK1MEN1KMT2AGRIK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242397-B1 TRANS OLEFINIC GLUCOKINASE ACTIVATORS HOFFMANN LA ROCHE (CH) 2005-09-28 EP disclosed
EP-1242397-A1 TRANS OLEFINIC GLUCOKINASE ACTIVATORS F. HOFFMANN-LA ROCHE AG (CH) 2002-09-25 EP disclosed
US-6353111-B1 WHICH INCREASE INSULIN SECRETION IN THE TREATMENT OF TYPE II DIABETES; 2,3-DI-SUBSTITUTED TRANS OLEFINIC N-HETEROAROMATIC OR URIDO PROPIONAMIDES: THE SUBSTITUTION AT THE 2-POSITION BEING A SUBSTITUTED PHENYL GROUP AND AT THE 3-POSITION A HOFFMANN-LA ROCHE INC. 2002-03-05 US disclosed
WO-2001044216-A1 TRANS OLEFINIC GLUCOKINASE ACTIVATORS F. HOFFMANN-LA ROCHE AG (CH) 2001-06-21 WO disclosed